Robert S. Lowe

1.7k citations
33 papers · 1.5k · h-index 22

Impact in

    • Cervical Cancer and HPV Research
    • Herpesvirus Infections and Treatments
  • Surgery top 5%
    • Lipoproteins and Cardiovascular Health
    • Cholesterol and Lipid Metabolism

Papers in

    • Lipoproteins and Cardiovascular Health 18
    • Cholesterol and Lipid Metabolism 1
    • Cervical Cancer and HPV Research 6
    • Herpesvirus Infections and Treatments 5

Robert S. Lowe

33 papers receiving 1.4k citations

Peers

Robert S. Lowe
Comparison fields: 5 of 73
  • Epidemiology 528
  • Surgery 629
  • Virology 28
  • Immunology 74
  • Animal Science and Zoology 35
Replace James K. Kelly with:
James K. Kelly Canada
Hans Christian Spangenberg Germany
Jiezuan Yang China
Maria A. Abadi United States
Michelle S. M. A. Damen United States
Bosco Ho‐Yin Wong Hong Kong
LIISA PYHÄLÄ Finland
Angela Rohwedder Germany
Guimei Li China
G. L. Toms United Kingdom
Robert S. Lowe relative to James K. Kelly Canada James K. Kelly's profile →
Citations per field
00.5×5×12×
James K. Kelly · 1×
Citations per year

Countries citing papers authored by Robert S. Lowe

Since Specialization
Citations

This map shows the geographic impact of Robert S. Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Lowe more than expected).

Fields of papers citing papers by Robert S. Lowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Lowe. The network helps show where Robert S. Lowe may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert S. Lowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert S. Lowe Line = papers co-authored together Robert S. Lowe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2012234
2 1986128
3 1997116
4 199992
5 200582
6 198778
7 200965
8 201165
9
Efficacy and Safety of Ezetimibe Added on to Atorvastatin (20 mg) Versus Uptitration of Atorvastatin (to 40 mg) in Hypercholesterolemic Patients at Moderately High Risk for Coronary Heart Disease††Conflicts of interest: Dr. Conard served as a consultant and advisor for Merck & Company and Merck/Schering-Plough. Dr. Bays received research grants from Amylin, San Diego, California, Amgen, Thousand Oaks, California, J&J, Langhorne, Pennsylvania, Aegerion, Bridgewater, New Jersey, Abbott, Chicago, Illinois, Arena Pharmaceuticals, San Diego, California, GlaxoSmithKline (Glaxo), London, UK, Hoffmann LaRoche, Nutley, New Jersey, Merck, Whitehouse Station, New Jersey, MSP, Kenilworth, New Jersey, Metabolex, San Jose, California, Schering-Plough, Kenilworth, New Jersey, Orexigen, San Diego, California, Reliant, Liberty Corner, New Jersey, Sciele, Atlanta, Georgia, Takeda, Osaka, Japan, TAP, Lake Forest, Illinois, and Vivus, Mountain View, California; received speakers' honoraria from Abbott, Daiichi Sankyo, Tokyo, Japan, GlaxoSmithKline, Reliant, Merck & Company, Merck/Schering-Plough, and Schering-Plough; received honoraria from Abbott, AstraZeneca, London, UK (Wilmington, Delaware, US Headquarters), Daiichi Sankyo, GlaxoSmithKline, Reliant, Merck & Company, Merck/Schering-Plough, and Schering-Plough; and served as a consultant and advisor for Abbott, GlaxoSmithKline, Metabolex, San Jose, California, Reliant, Takeda, AstraZeneca, and Essentialis, Carlsbad, California. Dr. Leiter received grants and speakers' honoraria from and served as a consultant and advisor for AstraZeneca, Merck & Company, Merck/Schering-Plough, and Pfizer, New York, New York. Mr. Bird, Mr. Rubino, and Drs. Lowe, Tomassini, and Tershakovec are employees of Merck & Company and may own stock and/or hold stock options in the company.
200864
10 201562
11 200049
12 198545
13 201343
14 198039
15 201137
16 200235
17 201233
18 198730
19 199730
20 201024

About Robert S. Lowe

Robert S. Lowe is a scholar working on Surgery, Epidemiology, Immunology, Genetics and Pharmacology, having authored 33 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (18 papers), Cervical Cancer and HPV Research (6 papers), Herpesvirus Infections and Treatments (5 papers), T-cell and Retrovirus Studies (2 papers), Cholesterol and Lipid Metabolism (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Pharmacogenetics and Drug Metabolism (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Epidemiology (528 citations), Surgery (629 citations), Virology (28 citations), Immunology (74 citations) and Animal Science and Zoology (35 citations). Robert S. Lowe has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Paul Malcolm Keller, Andrew M. Tershakovec, Ronald W. Ellis, Jianxin Lin, Arvind Shah, Andrew J. Davison, Mary Elizabeth Hanson, Kathrin Ute Jansen, Peter Paul Toth and Doralisa Morrone. Their work appears in journals such as Journal of Virology, The American Journal of Cardiology, Journal of clinical lipidology, Atherosclerosis and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact